Keyword: Mayo Clinic

Rheostat Therapeutics raised $23 million to develop treatments for neurodegenerative and rare diseases by targeting the cell’s garbage disposal.

The Mayo Clinic and Helix launched a new personal genomics product aimed at providing healthy individuals with DNA testing focusing on education.

Mayo Clinic and OmniTier have shown that de novo whole genome sequencing can be done without the need for “supercomputing-level resources."

Researchers have discovered seven gene alterations that could improve surveillance for triple-negative breast cancer risk.

New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.

Exact Sciences and the Mayo Clinic developed a DNA-based blood panel that detects 95% of all stages of liver cancer and outperforms common serum tests.

The Mayo Clinic and AliveCor showed how AI can identify increased risks of arrhythmias and sudden cardiac death despite a normal rhythm on an EKG.

The investment sets the Kite Pharma-partnered firm up to refine software to orchestrate the many steps involved in the production of cell therapies.

The IPO comes as the Flagship startup prepares to test its lead inflammatory disease and anticancer microbial strains in humans.

The new funding will propel Unity Biotechnology's osteoarthritis asset into its first clinical trial.